» Articles » PMID: 31387942

Basement Membrane Collagens and Disease Mechanisms

Overview
Journal Essays Biochem
Specialty Biochemistry
Date 2019 Aug 8
PMID 31387942
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Basement membranes (BMs) are specialised extracellular matrix (ECM) structures and collagens are a key component required for BM function. While collagen IV is the major BM collagen, collagens VI, VII, XV, XVII and XVIII are also present. Mutations in these collagens cause rare multi-systemic diseases but these collagens have also been associated with major common diseases including stroke. Developing treatments for these conditions will require a collective effort to increase our fundamental understanding of the biology of these collagens and the mechanisms by which mutations therein cause disease. Novel insights into pathomolecular disease mechanisms and cellular responses to these mutations has been exploited to develop proof-of-concept treatment strategies in animal models. Combined, these studies have also highlighted the complexity of the disease mechanisms and the need to obtain a more complete understanding of these mechanisms. The identification of pathomolecular mechanisms of collagen mutations shared between different disorders represent an attractive prospect for treatments that may be effective across phenotypically distinct disorders.

Citing Articles

IDH1 R132H and TP53 R248Q Mutations Modulate Glioma Cell Migration and Adhesion on Different ECM Components.

Shmelev M, Pilnik A, Shved N, Penkova A, Gulaia V, Kumeiko V Int J Mol Sci. 2024; 25(22).

PMID: 39596246 PMC: 11594609. DOI: 10.3390/ijms252212178.


Bacterial-host adhesion dominated by collagen subtypes remodelled by osmotic pressure.

Xu H, Feng Y, Du Y, Han Y, Duan X, Jiang Y NPJ Biofilms Microbiomes. 2024; 10(1):124.

PMID: 39532878 PMC: 11557999. DOI: 10.1038/s41522-024-00600-x.


Identification of basement membrane-related prognostic model associated with the immune microenvironment and synthetic therapy response in pancreatic cancer: integrated bioinformatics analysis and clinical validation.

Zhang B, Chen X, Song H, Gao X, Ma S, Ji H J Cancer. 2024; 15(19):6273-6298.

PMID: 39513120 PMC: 11540510. DOI: 10.7150/jca.100891.


Clinical and Molecular Findings in Patients with Knobloch Syndrome 1: Case Series Report.

Vasilyeva T, Kadyshev V, Khalanskaya O, Kuznetsova S, Ionova S, Marakhonov A Genes (Basel). 2024; 15(10).

PMID: 39457419 PMC: 11506921. DOI: 10.3390/genes15101295.


Distinct muscle regenerative capacity of human induced pluripotent stem cell-derived mesenchymal stromal cells in Ullrich congenital muscular dystrophy model mice.

Yokomizo-Goto M, Takenaka-Ninagawa N, Zhao C, Bourgeois Yoshioka C, Miki M, Motoike S Stem Cell Res Ther. 2024; 15(1):340.

PMID: 39370505 PMC: 11457425. DOI: 10.1186/s13287-024-03951-6.


References
1.
Heinonen S, Mannikko M, Klement J, Murphy G, Uitto J . Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J Cell Sci. 1999; 112 ( Pt 21):3641-8. DOI: 10.1242/jcs.112.21.3641. View

2.
Lu W, Phillips C, Killen P, Hlaing T, HARRISON W, Elder F . Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. Genomics. 1999; 61(2):113-24. DOI: 10.1006/geno.1999.5943. View

3.
Tasanen K, Floeth M, Schumann H, Bruckner-Tuderman L . Hemizygosity for a glycine substitution in collagen XVII: unfolding and degradation of the ectodomain. J Invest Dermatol. 2000; 115(2):207-12. DOI: 10.1046/j.1523-1747.2000.00049.x. View

4.
Cosgrove D, Rodgers K, Meehan D, Miller C, BOVARD K, GILROY A . Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Am J Pathol. 2000; 157(5):1649-59. PMC: 1885718. DOI: 10.1016/s0002-9440(10)64802-x. View

5.
Eklund L, Piuhola J, Komulainen J, Sormunen R, Ongvarrasopone C, Fassler R . Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice. Proc Natl Acad Sci U S A. 2001; 98(3):1194-9. PMC: 14731. DOI: 10.1073/pnas.98.3.1194. View